BALAXI PHARMACEUTICALS LIMITED — Others, 10-03-2025: Price movement

Balaxi Pharmaceuticals Limited has provided clarification regarding recent significant price movements of its shares. The company stated that there is no pending material information that would impact the stock's behavior, attributing the price fluctuations to market dynamics. Balaxi emphasizes its commitment to comply with SEBI regulations and ensure timely disclosures in the future. This assurance might contribute to a positive outlook among investors, alleviating concerns about volatility due to undisclosed developments. Overall, the company's transparency reinforces investor confidence in its governance and operational integrity.